BioGenes Celebrates 25 Years of Excellence in Quality Control of Biotherapeutics

July 25, 2017 – BioManufacturing

Berlin, Germany, July 25, 2017 / B3C newswire/ — BioGenes GmbH,
specializing in ELISA development and production, is celebrating its
25-year anniversary. In 1992 the scientists Dr. Alexander Knoll and Dr.
Sergej Ovodov set out with a vision to provide services and kits for the
quality control of biotherapeutics. Over the course of the last 25
years, BioGenesís vision has become a reality. BioGenes has grown from a
small niche start-up firm providing antibody services to a worldwide
leading provider of host cell protein (HCP) assays, customized ELISA
development and analytical services.

Company founder and CEO Dr.
Alexander Knoll remarked: “This is an incredible milestone for our
company. The company has achieved this success through the hard work,
passion, and dedication of our team members and our culture of customer
service that exists throughout the entire organization. Iím proud to say
that our teams consistently exceed client expectations by providing the
most efficient, and proactive services to each and every project.’

“To
this day BioGenes is still driven by the entrepreneurial spirit of our
founders, which has enabled us to constantly expand our offering
portfolio,” said Dagmar Schwertner, Marketing & Sales Director, who
has been with the company for 23 years. “In the fall, BioGenes will be
launching a new product for immunogenicity testing.’ As of today,
BioGenesí offerings include:

1. Customized ELISA Development

2.
Multi-product (platform) and specific HCP assays

3. Generic HCP ELISAs
(360-HCP assays for CHO cells and E.coli)

4. Customized Antibodies
(incl. anti-idiotypic antibodies)

5. Analytical Services (2D DIGE, 2D
Western Blot, HCP coverage determination etc.)

In its 25 years, BioGenes
has delivered thousands of projects to our customers. Find out more
about BioGenes at www.BioGenes.de

Koepenicker Str. 325 D-12555 Berlin Germany